Leigh Anne Tang, Michelle Gomez, Uday Suresh, Kristopher A Kast, Robert A Becker, Thomas J Reese, Colin G Walsh, Jessica S Ancker
{"title":"Clinician Perspectives on a Predictive Model for Recommending Opioid Use Disorder Treatment.","authors":"Leigh Anne Tang, Michelle Gomez, Uday Suresh, Kristopher A Kast, Robert A Becker, Thomas J Reese, Colin G Walsh, Jessica S Ancker","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Predictive models that have been made available as clinical decision support systems have not always been used. <b>Objectives:</b> This qualitative study aimed to identify factors that might impact the uptake of a predictive model recommending either methadone or buprenorphine as medication for opioid use disorder (MOUD) in the inpatient setting. <b>Methods:</b> We conducted semi-structured interviews with clinicians who prescribe MOUD and performed a combined deductive and inductive content analysis using a socio-technical model. <b>Results:</b> Thirteen clinicians were interviewed. Non-specialists trusted their specialist peers to lead MOUD decisions and claimed they would trust a tool endorsed by experts and the institution. Clinicians expected the model to follow clinical reasoning, which involves considering factors that are not well-captured by the electronic health record (e.g., housing status, access to care, facility preferences). <b>Conclusion:</b> Predictive models for MOUD should be designed to foster appropriate trust given the tool's purpose, process, limitation, and performance.</p>","PeriodicalId":72180,"journal":{"name":"AMIA ... Annual Symposium proceedings. AMIA Symposium","volume":"2024 ","pages":"1109-1118"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12099360/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMIA ... Annual Symposium proceedings. AMIA Symposium","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Predictive models that have been made available as clinical decision support systems have not always been used. Objectives: This qualitative study aimed to identify factors that might impact the uptake of a predictive model recommending either methadone or buprenorphine as medication for opioid use disorder (MOUD) in the inpatient setting. Methods: We conducted semi-structured interviews with clinicians who prescribe MOUD and performed a combined deductive and inductive content analysis using a socio-technical model. Results: Thirteen clinicians were interviewed. Non-specialists trusted their specialist peers to lead MOUD decisions and claimed they would trust a tool endorsed by experts and the institution. Clinicians expected the model to follow clinical reasoning, which involves considering factors that are not well-captured by the electronic health record (e.g., housing status, access to care, facility preferences). Conclusion: Predictive models for MOUD should be designed to foster appropriate trust given the tool's purpose, process, limitation, and performance.